Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Patrick K Owiafe"'
Autor:
Ulrike K Buchwald, Ifedayo M O Adetifa, Christian Bottomley, Patrick K Owiafe, Simon Donkor, Adama L Bojang, Jayne S Sutherland
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e116268 (2014)
The identification of Mycobacterium-tuberculosis (Mtb) infected individuals remains a challenge due to an insufficient understanding of immune responses detected with the current diagnostic tests for latent tuberculosis i.e. the tuberculin skin test
Externí odkaz:
https://doaj.org/article/6475696221f34f8fab4c1a7b07ce6f09
Autor:
Roger H Brookes, Philip C Hill, Patrick K Owiafe, Hannah B Ibanga, David J Jeffries, Simon A Donkor, Helen A Fletcher, Abdulrahman S Hammond, Christian Lienhardt, Richard A Adegbola, Helen McShane, Adrian V S Hill
Publikováno v:
PLoS ONE, Vol 3, Iss 8, p e2921 (2008)
Vaccination with a recombinant modified vaccinia Ankara expressing antigen 85A from Mycobacterium tuberculosis, MVA85A, induces high levels of cellular immune responses in UK volunteers. We assessed the safety and immunogenicity of this new vaccine i
Externí odkaz:
https://doaj.org/article/697f4bd9c458402b84d34e49123f0eb1
Autor:
Abel Makija Nlankpe, David Adedia, Precious Kwablah Kwadzokpui, Jacob Nabei Nignan, Patrick K. Owiafe
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2021 (2021)
BioMed Research International, Vol 2021 (2021)
Background and Objectives. Chronic hepatitis B and C infections are capable of progressing to liver cirrhosis and hepatocellular carcinoma. Globally, it has been estimated that over 2 billion and 170 million people are living with hepatitis B and C i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8cca0528e48185f88c44213c7eb52bc
https://doi.org/10.21203/rs.3.rs-149110/v1
https://doi.org/10.21203/rs.3.rs-149110/v1
Autor:
Simon Donkor, Ifedayo M. O. Adetifa, Patrick K. Owiafe, Abdulrahman S. Hammond, Martin O. C. Ota, Philip C. Hill, Moses D. Lugos, Roger H. Brookes, Lindsay Kendall
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 97:429-432
Tobacco use is a major risk factor for tuberculosis (TB). Secondhand smoke (SHS) is also a risk factor for TB and to a lesser extent, Mycobacterium tuberculosis infection without disease. We investigated the added risk of M. tuberculosis infection du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3f5393e87ec0cf02975e421392f06df
https://doi.org/10.4269/ajtmh.16-0611
https://doi.org/10.4269/ajtmh.16-0611
Autor:
Kurt Dobbelaere, Olumuyiwa Owolabi, Martin Antonio, Aderonke Odutola, Dorota Borys, Martin Okechukwu C. Ota, Archibald Worwui, Brian Greenwood, Magali Traskine, Ezra O. Ogundare, Yauba Saidu, Kristien Swinnen, Olubukola T. Idoko, Mark R. Alderson, Beate Kampmann, Patrick K. Owiafe, Vincent Verlant
Background Two conserved pneumococcal proteins, pneumolysin toxoid (dPly) and pneumococcal histidine triad protein D (PhtD), combined with 10 polysaccharide conjugates from the pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vacc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d447ea6a433a1c02ae9baf61ddef527b
Autor:
Simon Donkor, Olumuyiwa Owolabi, Jayne S. Sutherland, Patrick K. Owiafe, Schadrac C. Agbla, Martin O. C. Ota, Toyin Togun, Abdou K. Sillah
Publikováno v:
Tuberculosis (Edinburgh, Scotland)
Summary Background Vitamin D is essential in the host defence against tuberculosis (TB) as an immune modulator. The aim of this study was to determine the level of 25-hydroxyvitamin D (25 (OH) D) from adult TB index cases before and after treatment a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::992fc01b90d1bf7caf29e2336b2fbd3c
Autor:
Martin O. C. Ota, Archibald Worwui, Aderonke Odutola, Patrick K. Owiafe, Brian Greenwood, Kurt Dobbelaere, Magali Traskine, Ezra O. Ogundare, Vincent Verlant, Dorota Borys, Martin Antonio, Mark R. Alderson
Publikováno v:
Human Vaccines & Immunotherapeutics
Pneumococcal conjugate vaccines (PCVs) have been successful in preventing invasive pneumococcal disease but effectiveness has been challenged by replacement of vaccine serotypes with non-vaccine serotypes. Vaccines targeting common pneumococcal prote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bf2fb9e6923ee867e2435000535da5a
https://doi.org/10.1080/21645515.2015.1111496
https://doi.org/10.1080/21645515.2015.1111496
Autor:
Nana Yaw Barimah Manaphraim, Tibemponi Ntoni, Mavis Popuelle Dakorah, Gameli Kwame Norgbe, Patrick K. Owiafe, Roseline Avorkliyah, Edward Yiadom Boakye, Sylvester Yao Lokpo, Felix Ayroe, Francis Abeku Ussher, Emmanuel Akomanin Asiamah, John Gameli Deku, Prince Senyo Kwasi Nyamadi, James Osei-Yeboah
Publikováno v:
Hepatitis Research and Treatment
Background. Using prospective blood donors as a proxy, this study was aimed at estimating the burden and five-year (2012–2016) trend of viral hepatitis (HBV and HCV) infection among asymptomatic adult population in Ho. Materials and Methods. A retr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67eb3f29d295cbfc20cfd283be170099
http://europepmc.org/articles/PMC5694981
http://europepmc.org/articles/PMC5694981
Autor:
Mark R. Alderson, Kurt Dobbelaere, Magali Traskine, Ezra O. Ogundare, Yauba Saidu, Brian Greenwood, Isatou Drammeh, Abdoulie Bojang, Sonia Schoonbroodt, Kristien Swinnen, Archibald Worwui, Beate Kampmann, Olumuyiwa Owolabi, Vincent Verlant, Martin Antonio, Nathalie Devos, Fatima Ceesay, Sheikh Jarju, Martin O. C. Ota, Ebenezer Foster-Nyarko, Dorota Borys, Aderonke Odutola, Olubukola T. Idoko, Patrick K. Owiafe
Background Conserved pneumococcal proteins are potential candidates for inclusion in vaccines against pneumococcal diseases. In the first part of a two-part study, an investigational vaccine (PHiD-CV/dPly/PhtD-30) containing 10 pneumococcal serotype-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd61e9fe0b86d96228263290b2f67972
Autor:
Roger H. Brookes, Hannah B. Ibanga, Helen McShane, Martin O. C. Ota, Philip C. Hill, Jayne S. Sutherl, Patrick K. Owiafe
MVA85A is a candidate boost vaccine for TB. A previously reported study showed no differences in response to MVA85A in 10 BCG vaccinated (BCG+) and 11 BCG naive (BCG-) adult Gambians. Here we evaluated the effect of pre-existing plasma cytokines in b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4236f182abc1de303d5a2d45b87cab1
https://doi.org/10.4172/2157-7560.1000158
https://doi.org/10.4172/2157-7560.1000158